
GLP-1 Receptor Agonists Demonstrate Anti-Cancer Effects Independent of Weight Loss
A groundbreaking study presented at the European Congress on Obesity (ECO) in Malaga, Spain, unveils compelling evidence that first-generation glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as liraglutide and exenatide may confer significant …